FIFTH THIRD BANCORP - DIPLOMAT PHARMACY INC ownership

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2018$25,000
-32.4%
976
-46.5%
0.00%
Q1 2018$37,000
-2.6%
1,823
-4.9%
0.00%
Q4 2017$38,000
+72.7%
1,917
+77.7%
0.00%
Q3 2017$22,000
+37.5%
1,0790.0%0.00%
Q2 2017$16,000
-5.9%
1,0790.0%0.00%
Q1 2017$17,000
+21.4%
1,0790.0%0.00%
Q4 2016$14,000
-60.0%
1,079
-14.2%
0.00%
Q3 2016$35,000
+12.9%
1,257
+44.0%
0.00%
Q2 2016$31,000
+34.8%
873
+2.8%
0.00%
Q1 2016$23,000
-32.4%
849
-15.4%
0.00%
Q4 2015$34,000
+70.0%
1,004
+42.2%
0.00%
Q3 2015$20,000
-42.9%
706
-9.3%
0.00%
Q2 2015$35,000
+105.9%
778
+55.6%
0.00%
Q1 2015$17,0005000.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 452,018$11,554,00010.87%
KETTLE HILL CAPITAL MANAGEMENT, LLC 195,126$4,987,0001.90%
Capital Investment Advisory Services, LLC 144,182$3,685,0001.84%
Investors Research Corp 95,150$2,432,0001.41%
Redwood Investments, LLC 783,983$20,039,0001.38%
Cortina Asset Management, LLC 1,085,078$27,735,0001.30%
Pier Capital, LLC 362,328$9,261,0001.27%
Matarin Capital Management, LLC 628,786$16,071,770,0001.16%
BROADVIEW ADVISORS LLC 264,800$6,768,0001.08%
DARUMA CAPITAL MANAGEMENT LLC 592,659$15,148,0000.98%
View complete list of DIPLOMAT PHARMACY INC shareholders